Premenstrual syndrome. Pain and other conditions associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention 1: Omega-3, one gram capsule, twice daily, everyday in the first month and since 8 days before mentstruation till 2 days after begining of bleeding in the second and third months. Interve
Treatment - Drugs
Placebo
Omega-3, one gram capsule, twice daily, everyday in the first month and since 8 days before mentstruation till 2 days after begining of bleeding in the second and third months
Placebo, one gram capsule, twice daily, everyday in the first month and since 8 days before mentstruation till 2 days after begining of bleeding in the second and third months
Sponsors
Tarbiat Modares University
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 20-35 years, single girls, normal cycle (duration of cycle 22-35, bleeding 3-7 days), normal BMI (18.5-25), PMS according to PSST questionnaire Exclusion criteria: any history of disease such as hepatic, renal, or respiratory cardiac, diabetes, or respiratory diseases, presence of secondary dysmenorrheal, sea food allergy, use of alcohol, smoking, presence of chronic diseases such as like migraine, use of any drug affecting PMS such as OCP or B6, stressful condition like death of family members
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Premenstrual syndrome (existing symptoms in PSST questionnaire. Timepoint: before intervention, 1, 2, and 3 months after intervention. Method of measurement: PSST questionnaire.;Quality of life. Timepoint: before intervention, 1, 2, and 3 month after intervention. Method of measurement: SF-12 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemehZahra Hariri
Tarbiat Modares University
Outcome results
None listed